ACR.AX
Price:
$0.033
Market Cap:
$13.27M
Acrux Limited, together with its subsidiaries, develops and commercializes generic and topical pharmaceuticals in Australia, Europe, the United States, and internationally. The company offers testosterone solutions, such as oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels for treatment of adult males who have low or no testosterone. It also provides estradiol sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause. The company was incorporated in 1998 and is based in West Melbourne, Australia.[Read more]
Industry
Biotechnology
IPO Date
2004-09-29
Stock Exchange
ASX
Ticker
ACR.AX
According to Acrux Limited’s latest financial reports and current stock price. The company's current Current Ratio is 1.61. This represents a change of -38.06% compared to the average of 2.59 of the last 4 quarters.
The mean historical Current Ratio of Acrux Limited over the last ten years is 6.69. The current 1.61 Current Ratio has changed 2.30% with respect to the historical average. Over the past ten years (40 quarters), ACR.AX's Current Ratio was at its highest in in the June 2010 quarter at 29.96. The Current Ratio was at its lowest in in the September 2008 quarter at 0.
Average
6.69
Median
6.34
Minimum
1.61
Maximum
11.78
Discovering the peaks and valleys of Acrux Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 97.94%
Maximum Annual Current Ratio = 11.78
Minimum Annual Increase = -61.17%
Minimum Annual Current Ratio = 1.61
Year | Current Ratio | Change |
---|---|---|
2024 | 1.61 | -61.17% |
2023 | 4.14 | 37.10% |
2022 | 3.02 | -55.09% |
2021 | 6.72 | 45.16% |
2020 | 4.63 | -46.57% |
2019 | 8.67 | -25.66% |
2018 | 11.66 | -1.01% |
2017 | 11.78 | 97.94% |
2016 | 5.95 | -31.98% |
2015 | 8.75 | 68.83% |
The current Current Ratio of Acrux Limited (ACR.AX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.92
5-year avg
4.02
10-year avg
6.69
Acrux Limited’s Current Ratio is less than Pharmaxis Ltd (7.21), less than Starpharma Holdings Limited (4.94), less than Bionomics Limited (3.30), less than Antisense Therapeutics Limited (0), less than Ainsworth Game Technology Limited (2.18),
Company | Current Ratio | Market cap |
---|---|---|
7.21 | $20.23M | |
4.94 | $45.99M | |
3.30 | $13.22M | |
0 | $52.29M | |
2.18 | $250.91M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acrux Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Acrux Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Acrux Limited's Current Ratio?
How is the Current Ratio calculated for Acrux Limited (ACR.AX)?
What is the highest Current Ratio for Acrux Limited (ACR.AX)?
What is the 3-year average Current Ratio for Acrux Limited (ACR.AX)?
What is the 5-year average Current Ratio for Acrux Limited (ACR.AX)?
How does the current Current Ratio for Acrux Limited (ACR.AX) compare to its historical average?